Tuesday AM August 26th, 2008

image of Fairway Medical Technologies logoA Houston company has a three-year contract with the Navy to help develop instruments for detecting chemical and biological agents. Ed Mayberry reports.


To embed this piece of audio in your site, please use this code:

<iframe src="" style="height: 115px; width: 100%;"></iframe>

Fairway Medical Technologies is applying optoacoustic technology to develop a rugged instrument for use by the Navy on the battlefield capable of detecting anthrax, plague and smallpox. Jim Meador is president of the Houston company.

“Optoacoustics is actually discovered by Alexander Graham Bell, and it’s the translation of light energy into sound energy.”

Ed: “And what will this research lead to?”

“A combination of a re-agent, if you will, and and an instrument to be able to rapidly test fluid samples for the presence of organisms of interest, or things that terrorists may try to introduce into a water supply system, as an example.”

Meador says Fairway will manufacture the devices for the Navy and other Department of Defense customers when research and development concludes.

“It’ll mean further expansion of our facilities and further validation of our business model to find new and market disruptive technologies; further validation of the optoacoustic technology, which was invented by our VP of research and development, Alexander Oraevsky.”
Fairway Medical Technologies has more than doubled its manufacturing and research capacity in the past 24 months. The private company has five federally-sponsored government grants — three based on cancer and a couple on nanotecnology.

Ed Mayberry, Houston Public Radio News.

Subscribe to Today in Houston

Fill out the form below to subscribe our new daily editorial newsletter from the HPM Newsroom.

* required